Passive Pre-Exposure Immunization by Tixagevimab/cilgavimab in Patients with Hematological Malignancy and COVID-19: Matched-Paired Analysis in the EPICOVIDEHA Registry Francesco Marchesi , Jon Salmanton-García , Caterina Buquicchio , Federico Itri , Caroline Besson , Julio Dávila-Valls , Sonia Martín-Pérez , Luana Fianchi , Laman Rahimli , Giuseppe Tarantini , Federica Irene Grifoni , Mariarita Sciume , Jorge Labrador , Raul Cordoba , Alberto López-García , Nicola S. Fracchiolla , Francesca Farina , Emanuele Ammatuna , Antonella Cingolani , Daniel García-Bordallo , Stefanie K. Gräfe , Yavuz M. Bilgin , Michelina Dargenio , Tomás José González-López , Anna Guidetti , Tobias Lahmer , Esperanza Lavilla-Rubira , Gustavo-Adolfo Méndez , Lucia Prezioso , Martin Schönlein , Jaap Van Doesum , Dominik Wolf , Ditte Stampe Hersby , Ferenc Magyari , Jens Van Praet , Verena Petzer , Carlo Tascini , Iker Falces-Romero , Andreas Glenthøj , Oliver A. Cornely , Livio Pagano ONCOLOGY RESEARCH AND TREATMENT（2023）
Key words
COVID-19, Passive immunization, Tixagevimab/cilgavimab, Hematologic malignancies
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
